ArticleHealth services insights2026
Patient Perspectives of Healthcare for Premenstrual Dysphoric Disorder in Australia: A Mixed-Methods Study.
Article in Health services insights, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Premenstrual Dysphoric Disorder (PMDD) is associated with higher suicidality and reduced functioning. Diagnosis and treatment can improve symptoms and quality of life. Poor quality healthcare experiences for people seeking help for PMDD have been documented in other countries, but not in Australia. Objective: To quantitatively and qualitatively describe experiences of healthcare for PMDD in Australia, including variations in experience by healthcare provider (HCP) type. Methods: We employed mixed methods including an online survey and semi-structured interviews in adults who had sought healthcare in Australia for PMDD symptoms. Quantitative data was analysed using descriptive statistics, chi-square analyses, Results: Survey participants (n = 267) had sought help from an average of 5.1 different HCPs in seeking PMDD diagnosis and perceived an average of 51% of HCPs they had seen to have poor PMDD awareness. GPs were the most frequent HCP type seen first (74%) when seeking diagnosis. More than half reported experiencing medical gaslighting (54%) and misdiagnosis (56%). Interview participants (n = 11) reported misdiagnoses such as depression, anxiety, bipolar disorder, and personality disorders. Interview participants reported feeling that their symptoms were minimised by healthcare providers and that their health care concerns were dismissed. Participants were more likely to report poorer experiences with GPs compared to other HCP types. Less than a fifth of the survey sample (19%) had experienced diagnostic methods consistent with DSM-TR recommendations. Diagnosis was described by interview participants as resulting in increased coping, a mindset of self-compassion and reduced self-perceptions of feeling 'crazy' or having fundamental personality flaws. Conclusions: People in Australia face similar PMDD healthcare barriers to those documented elsewhere. GP training in PMDD screening and clearer patient care pathways with specialist referral are needed to improve healthcare provision and reduce the burden of PMDD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.